Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100056092> ?p ?o ?g. }
- W2100056092 endingPage "1641" @default.
- W2100056092 startingPage "1627" @default.
- W2100056092 abstract "Worldwide, rotaviruses are the single most important agents of severe gastroenteritis in infants and young children. Globally, it is estimated that every year rotavirus gastroenteritis causes more than 125 million episodes of diarrhea and nearly 527,000 deaths, mainly in developing countries. The development of new effective and safe rotavirus vaccines was recognized as the most effective intervention strategy that could yield a significant impact on the burden of rotavirus disease. Rotarix™ is an oral live-attenuated human rotavirus vaccine containing a single G1P[8] strain. The first oral dose may be administered as early as 6 weeks of age, with a minimum interval of 4 weeks prior to second dose; the vaccination course should be completed by the age of 24 weeks according to the manufacturer. In the USA, the upper age limit for the second dose has recently been recommended at 32 weeks of age by the Advisory Committee on Immunization Practices. The development program for Rotarix including Phase I, II and III multicenter studies involving over 100,000 infants has been established in Latin America, Europe, Asia and Africa. The vaccine proved to be well tolerated, immunogenic, efficacious, safe and not associated with intussusception. It provided 85–96% protection against severe rotavirus gastroenteritis caused by G1 and non-G1 serotypes in Latin American and European clinical trials; and of public health importance, Rotarix reduced hospitalizations of all-cause gastroenteritis by 40 and 75%, respectively. Efficacy against G2P[4] strains ranged from 41% in Latin America to 81% in Europe. In the former, Rotarix afforded sustained high protection (80.5%; 95% CI: 71.3–87.1) against severe rotavirus gastroenteritis during the first 2 years of life in a region with a changing pattern of wild-type rotavirus circulation. In a recently completed vaccine trial in South Africa and Malawi, Rotarix showed an overall efficacy of 61.2% (95% CI: 44.0–73.2) by 1 year of age. Although these rates are lower than those from developed and middle-income countries, they look promising given the lack of other effective interventions. With the expanding introduction of rotavirus vaccines into national immunization programs, postmarketing surveillance should be conducted to measure the impact of rotavirus vaccination, as well as continued monitoring of circulating rotavirus strains." @default.
- W2100056092 created "2016-06-24" @default.
- W2100056092 creator A5021404644 @default.
- W2100056092 creator A5064885439 @default.
- W2100056092 date "2009-12-01" @default.
- W2100056092 modified "2023-09-23" @default.
- W2100056092 title "Update on Rotarix™: an oral human rotavirus vaccine" @default.
- W2100056092 cites W1964705610 @default.
- W2100056092 cites W1966417805 @default.
- W2100056092 cites W1969821154 @default.
- W2100056092 cites W1973925842 @default.
- W2100056092 cites W1976741530 @default.
- W2100056092 cites W1981173411 @default.
- W2100056092 cites W1981780275 @default.
- W2100056092 cites W1982045163 @default.
- W2100056092 cites W1985494124 @default.
- W2100056092 cites W1992908224 @default.
- W2100056092 cites W1993454254 @default.
- W2100056092 cites W1994551223 @default.
- W2100056092 cites W2000093434 @default.
- W2100056092 cites W2002705343 @default.
- W2100056092 cites W2006763045 @default.
- W2100056092 cites W2012555213 @default.
- W2100056092 cites W2016857079 @default.
- W2100056092 cites W2017289264 @default.
- W2100056092 cites W2025825444 @default.
- W2100056092 cites W2029655227 @default.
- W2100056092 cites W2030480685 @default.
- W2100056092 cites W2039605694 @default.
- W2100056092 cites W2040393189 @default.
- W2100056092 cites W2045633904 @default.
- W2100056092 cites W2049505598 @default.
- W2100056092 cites W2054126241 @default.
- W2100056092 cites W2059936214 @default.
- W2100056092 cites W2065942818 @default.
- W2100056092 cites W2076121434 @default.
- W2100056092 cites W2083047717 @default.
- W2100056092 cites W2083934734 @default.
- W2100056092 cites W2088419994 @default.
- W2100056092 cites W2088574260 @default.
- W2100056092 cites W2089843579 @default.
- W2100056092 cites W2094126785 @default.
- W2100056092 cites W2095204653 @default.
- W2100056092 cites W2095820230 @default.
- W2100056092 cites W2100178369 @default.
- W2100056092 cites W2101154874 @default.
- W2100056092 cites W2101852760 @default.
- W2100056092 cites W2107128060 @default.
- W2100056092 cites W2107847785 @default.
- W2100056092 cites W2110770373 @default.
- W2100056092 cites W2116936815 @default.
- W2100056092 cites W2121496714 @default.
- W2100056092 cites W2121632618 @default.
- W2100056092 cites W2123497124 @default.
- W2100056092 cites W2123830127 @default.
- W2100056092 cites W2127653958 @default.
- W2100056092 cites W2131073529 @default.
- W2100056092 cites W2131668453 @default.
- W2100056092 cites W2134988341 @default.
- W2100056092 cites W2141566887 @default.
- W2100056092 cites W2143233237 @default.
- W2100056092 cites W2146147908 @default.
- W2100056092 cites W2147180047 @default.
- W2100056092 cites W2153883091 @default.
- W2100056092 cites W2156167673 @default.
- W2100056092 cites W2157623048 @default.
- W2100056092 cites W2160702042 @default.
- W2100056092 cites W2163306701 @default.
- W2100056092 cites W2163696987 @default.
- W2100056092 cites W2165075526 @default.
- W2100056092 cites W2166083251 @default.
- W2100056092 cites W2168275109 @default.
- W2100056092 cites W2170749337 @default.
- W2100056092 cites W3123386098 @default.
- W2100056092 cites W4234915916 @default.
- W2100056092 cites W4236114911 @default.
- W2100056092 cites W4253384171 @default.
- W2100056092 cites W4362206875 @default.
- W2100056092 doi "https://doi.org/10.1586/erv.09.136" @default.
- W2100056092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19943758" @default.
- W2100056092 hasPublicationYear "2009" @default.
- W2100056092 type Work @default.
- W2100056092 sameAs 2100056092 @default.
- W2100056092 citedByCount "59" @default.
- W2100056092 countsByYear W21000560922012 @default.
- W2100056092 countsByYear W21000560922013 @default.
- W2100056092 countsByYear W21000560922014 @default.
- W2100056092 countsByYear W21000560922015 @default.
- W2100056092 countsByYear W21000560922016 @default.
- W2100056092 countsByYear W21000560922017 @default.
- W2100056092 countsByYear W21000560922018 @default.
- W2100056092 countsByYear W21000560922019 @default.
- W2100056092 countsByYear W21000560922020 @default.
- W2100056092 countsByYear W21000560922021 @default.
- W2100056092 countsByYear W21000560922022 @default.
- W2100056092 countsByYear W21000560922023 @default.
- W2100056092 crossrefType "journal-article" @default.
- W2100056092 hasAuthorship W2100056092A5021404644 @default.